What is the history of Paget's Disease?

Paget’s Disease of bone, first described by Sir James Paget in 1877, is a chronic skeletal disorder characterized by the disordered remodeling of bone tissue. Historically viewed as a rare inflammatory condition, our understanding of Paget's Disease has evolved through medical imaging and genetic discovery to identify it as a localized metabolic bone condition affecting approximately 1-2% of the population over the age of 55.

Who first described Paget's Disease?

The condition is named after the British surgeon Sir James Paget, who presented his findings on "osteitis deformans" to the Royal Medical and Chirurgical Society of London in 1877. Paget originally described five patients with progressive bone enlargement and deformity, initially mistaking the condition for a chronic inflammatory process. While Paget’s initial clinical observations were remarkably accurate, he lacked the radiographic tools to confirm his suspicions of the underlying cellular dysfunction.

How has our understanding of Paget's Disease evolved?

For decades, Paget's Disease was poorly understood, often leading to confusion with other bone malignancies. The introduction of X-rays in the early 20th century allowed physicians to distinguish Paget's Disease from other skeletal disorders by visualizing the characteristic "cotton wool" appearance of affected bone. Modern medical science now recognizes that Paget's Disease results from overactive osteoclasts—the cells responsible for breaking down bone—which leads to structurally weak and disorganized new bone formation.

What are the major milestones in treatment?

The management of Paget's Disease has undergone a significant transformation, moving from supportive care to targeted pharmacological interventions:

• 1970s: The introduction of calcitonin, the first effective medical therapy to slow bone resorption.


• 1980s-90s: The development of bisphosphonates, which remain the gold standard for managing Paget's Disease by inhibiting bone turnover.


• 2000s-Present: The identification of the SQSTM1 gene, confirming a genetic predisposition in roughly 10-40% of familial cases.

Next steps

• Consult an endocrinologist or rheumatologist if you experience persistent bone pain or unexplained skeletal deformity.


• Request a blood test for alkaline phosphatase (ALP) levels, a primary marker for disease activity.


• Join a supportive community like DiseaseMaps.org to connect with others currently living with Paget's Disease.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Paget's Disease of Bone


• Orphanet: Paget's disease of bone (ORPHA:2804)


• OMIM (Online Mendelian Inheritance in Man): Paget Disease of Bone 1 (PDB1)


• The Paget Foundation for Paget's Disease of Bone and Related Disorders